Clinical Trial Update: A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

View source ↗

Summary

A prospective registry study evaluating real-world patient characteristics, treatment patterns, and outcomes in obstructive hypertrophic cardiomyopathy patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Camzy (mavacamten)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Obstructive Hypertrophic Cardiomyopathy | Status: RECRUITING